SG11201401024VA - System for non-invasive assay of liver funtion - Google Patents

System for non-invasive assay of liver funtion

Info

Publication number
SG11201401024VA
SG11201401024VA SG11201401024VA SG11201401024VA SG11201401024VA SG 11201401024V A SG11201401024V A SG 11201401024VA SG 11201401024V A SG11201401024V A SG 11201401024VA SG 11201401024V A SG11201401024V A SG 11201401024VA SG 11201401024V A SG11201401024V A SG 11201401024VA
Authority
SG
Singapore
Prior art keywords
funtion
liver
invasive assay
invasive
assay
Prior art date
Application number
SG11201401024VA
Inventor
Philip E Eggers
Eric A Eggers
Andrew R Eggers
Mark A Mayerchak
Original Assignee
Cardiox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiox Corp filed Critical Cardiox Corp
Publication of SG11201401024VA publication Critical patent/SG11201401024VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/0275—Measuring blood flow using tracers, e.g. dye dilution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
    • A61B5/4222—Evaluating particular parts, e.g. particular organs
    • A61B5/4244—Evaluating particular parts, e.g. particular organs liver
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6814—Head
    • A61B5/6815—Ear
    • A61B5/6816—Ear lobe

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
SG11201401024VA 2011-08-29 2012-08-29 System for non-invasive assay of liver funtion SG11201401024VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161528562P 2011-08-29 2011-08-29
PCT/US2012/052861 WO2013033212A1 (en) 2011-08-29 2012-08-29 System for non-invasive assay of liver funtion

Publications (1)

Publication Number Publication Date
SG11201401024VA true SG11201401024VA (en) 2014-09-26

Family

ID=47756830

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401024VA SG11201401024VA (en) 2011-08-29 2012-08-29 System for non-invasive assay of liver funtion

Country Status (7)

Country Link
US (1) US20120330116A1 (en)
EP (1) EP2750605A4 (en)
AU (1) AU2012302089A1 (en)
CA (1) CA2847254A1 (en)
IL (1) IL231262A0 (en)
SG (1) SG11201401024VA (en)
WO (1) WO2013033212A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9575087B2 (en) * 2012-09-06 2017-02-21 Parker-Hannifin Corporation Risk-managed, single-use, pre-calibrated, pre-sterilized sensors for use in bio-processing applications
JP6387409B2 (en) * 2013-10-23 2018-09-05 ヴェリリー ライフ サイエンシズ エルエルシー Spatial modulation of magnetic particles in vascular system by external magnetic field
US9636034B2 (en) * 2013-10-23 2017-05-02 Verily Life Sciences Llc Non-invasive analyte detection system with modulation source
US10542918B2 (en) 2013-10-23 2020-01-28 Verily Life Sciences Llc Modulation of a response signal to distinguish between analyte and background signals
US9874554B1 (en) 2014-07-16 2018-01-23 Verily Life Sciences Llc Aptamer-based in vivo diagnostic system
US9910035B1 (en) 2014-07-16 2018-03-06 Verily Life Sciences Llc Polyvalent functionalized nanoparticle-based in vivo diagnostic system
WO2016195034A1 (en) * 2015-06-04 2016-12-08 オリンパス株式会社 Ultrasonic endoscope and water pouring device
WO2017046182A1 (en) 2015-09-14 2017-03-23 Freie Universität Berlin Method for identifying a metabolite that is suited to be used in diagnostics of a liver disease or of a severity of a liver disease
US10150115B2 (en) * 2016-07-21 2018-12-11 Spacepharma SA System and method for rehydrating powder and delivering the rehydrated powder to a reactor
US11013436B2 (en) 2017-09-06 2021-05-25 Medtronic, Inc. Marker monitoring via a medical device
DE102020216541A1 (en) 2020-12-23 2022-06-23 Robert Bosch Gesellschaft mit beschränkter Haftung Device and method for a fluorescence measurement for an analysis of a biochemical sample

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE380440B (en) * 1972-11-17 1975-11-10 Dameco Medical Products Ab CENTRAL VENKATERIZATION SYSTEM
US6175759B1 (en) * 1999-06-28 2001-01-16 The United States Of America As Represented By The Secretary Of The Air Force Contrast agent for multispectral infrared transillumination and fluorescence of turbid media
US8337444B2 (en) * 2001-05-22 2012-12-25 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Measurement of cardiac output and blood volume by non-invasive detection of indicator dilution for hemodialysis
WO2006009910A2 (en) * 2004-06-17 2006-01-26 The Regents Of The University Of California Time-resolved optometric fluorescence detection for skin diagnostics
US8423125B2 (en) * 2004-11-09 2013-04-16 Spectrum Dynamics Llc Radioimaging
US7801589B2 (en) * 2005-12-22 2010-09-21 Olympus Corporation In-vivo examination method and in-vivo examination apparatus
EP2155315A1 (en) * 2007-06-13 2010-02-24 Catharos Medical Systems, Inc. Methods and devices for removal of a medical agent from a physiological efferent fluid collection site
US20090198217A1 (en) * 2008-02-06 2009-08-06 Gale H. Thome, JR. Convenience IV kits and methods of use
US20100016731A1 (en) * 2008-07-15 2010-01-21 Cardiox Corporation Hemodynamic Detection of Circulatory Anomalies

Also Published As

Publication number Publication date
EP2750605A4 (en) 2015-12-02
WO2013033212A1 (en) 2013-03-07
CA2847254A1 (en) 2013-03-07
US20120330116A1 (en) 2012-12-27
IL231262A0 (en) 2014-04-30
AU2012302089A1 (en) 2014-04-17
EP2750605A1 (en) 2014-07-09

Similar Documents

Publication Publication Date Title
HK1245110B (en) Solid forms of isoquinolinones
IL231262A0 (en) System for non-invasive assay of liver funtion
GB2501433B (en) Ensuring the integrity of software
EP2707510A4 (en) Isolation of nucleic acids
IL229254A0 (en) Therapeutic antibodies
HK1204604A1 (en) Stereoselective total synthesis of noribogaine
PL2735206T3 (en) Determination of the timing advance group
ZA201403108B (en) Purification of anti-c-met antibodies
IL227656A0 (en) Engineering of immunogolobulin domains
ZA201305972B (en) Method for the preparation of biphephos
SG11201401287SA (en) Methods of treating liver conditions using notch2 antagonists
SG11201400939YA (en) Process for the preparation of methoxymelonal
ZA201207397B (en) Process for the preparation of dexlansoprazole
IL238592B (en) Compounds for treatment of liver diseases
HK1199040A1 (en) Use of antibody
EP2684869A4 (en) Preparation of 3-mercaptopropionates
SG11201400090UA (en) Process for the preparation of olefins
EP2714713A4 (en) Purification of antibodies
PT2593423E (en) Process for the preparation of contrast agents
EP2804607A4 (en) Synthesis of raltegravir
GB201119690D0 (en) Process for the preparation of compounds
GB201113815D0 (en) Multi-photon isomerisation of transcombretastatins
PL393916A1 (en) Process for the preparation of carbapenemic compounds
ZA201309732B (en) Process for the preparation of dexlansoprazole
EP2785723A4 (en) Difluoromethylation of unsaturated compounds